Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $1.31 Million - $1.76 Million
-2,217 Reduced 83.13%
450 $350,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $721,611 - $850,684
1,374 Added 106.26%
2,667 $1.55 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $562,067 - $774,894
1,293 New
1,293 $694,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $226,138 - $265,588
-728 Reduced 47.09%
818 $280,000
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $430,916 - $505,959
1,546 New
1,546 $509,000
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $2.73 Million - $3.54 Million
-16,634 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$130.46 - $172.63 $1.45 Million - $1.92 Million
11,108 Added 201.01%
16,634 $2.76 Million
Q3 2020

Nov 02, 2020

BUY
$146.22 - $169.13 $808,011 - $934,612
5,526 New
5,526 $858,000
Q2 2020

Jul 29, 2020

SELL
$136.42 - $164.18 $607,069 - $730,601
-4,450 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$119.05 - $147.35 $529,772 - $655,707
4,450 New
4,450 $637,000
Q3 2019

Oct 31, 2019

SELL
$106.79 - $116.16 $1.13 Million - $1.23 Million
-10,556 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $704,181 - $821,957
6,356 Added 151.33%
10,556 $1.12 Million
Q1 2019

Apr 15, 2019

BUY
$111.31 - $131.02 $467,502 - $550,284
4,200 New
4,200 $536,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $1.36 Million - $1.52 Million
-12,819 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $1.1 Million - $1.38 Million
12,819 New
12,819 $1.38 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $861,652 - $1.02 Million
-11,611 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $951,405 - $1.02 Million
11,611
11,611 $993,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.